Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Development of Standard Reference Materials to support assessment of iodine status for nutritional and public health purposes.

Long SE, Catron BL, Boggs AS, Tai SS, Wise SA.

Am J Clin Nutr. 2016 Sep;104 Suppl 3:902S-6S. doi: 10.3945/ajcn.115.110361. Review.

PMID:
27534629
2.

Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.

Jalily PH, Eldstrom J, Miller SC, Kwan DC, Tai SS, Chou D, Niikura M, Tietjen I, Fedida D.

Mol Pharmacol. 2016 Aug;90(2):80-95. doi: 10.1124/mol.115.102731.

PMID:
27193582
3.

Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.

Arns S, Balgi AD, Shimizu Y, Pfeifer TA, Kumar N, Shidmoossavee FS, Sun S, Tai SS, Agafitei O, Jaquith JB, Bourque E, Niikura M, Roberge M.

Eur J Med Chem. 2016 Sep 14;120:64-73. doi: 10.1016/j.ejmech.2016.05.008.

PMID:
27187859
5.

Homology-based analysis of the GRAS gene family in tobacco.

Chen YQ, Tai SS, Wang DW, Ding AM, Sun TT, Wang WF, Sun YH.

Genet Mol Res. 2015 Nov 26;14(4):15188-200. doi: 10.4238/2015.November.25.7.

7.

Development of a Standard Reference Material for metabolomics research.

Phinney KW, Ballihaut G, Bedner M, Benford BS, Camara JE, Christopher SJ, Davis WC, Dodder NG, Eppe G, Lang BE, Long SE, Lowenthal MS, McGaw EA, Murphy KE, Nelson BC, Prendergast JL, Reiner JL, Rimmer CA, Sander LC, Schantz MM, Sharpless KE, Sniegoski LT, Tai SS, Thomas JB, Vetter TW, Welch MJ, Wise SA, Wood LJ, Guthrie WF, Hagwood CR, Leigh SD, Yen JH, Zhang NF, Chaudhary-Webb M, Chen H, Fazili Z, LaVoie DJ, McCoy LF, Momin SS, Paladugula N, Pendergrast EC, Pfeiffer CM, Powers CD, Rabinowitz D, Rybak ME, Schleicher RL, Toombs BM, Xu M, Zhang M, Castle AL.

Anal Chem. 2013 Dec 17;85(24):11732-8. doi: 10.1021/ac402689t.

8.
9.

In Reply.

Vesper HW, Botelho JC, Tai SS, Van Uytfanghe K, Thienpont LM.

Clin Chem. 2013 Jul;59(7):1130-1. No abstract available.

10.

A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients.

Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL.

Transplantation. 2013 May 27;95(10):1233-41. doi: 10.1097/TP.0b013e318291a269.

PMID:
23689085
11.

The development and implementation of quality assurance programs to support nutritional measurements.

Sander LC, Bedner M, Duewer DL, Lippa KA, Phillips MM, Phinney KW, Rimmer CA, Schantz MM, Sharpless KE, Tai SS, Thomas JB, Wise SA, Wood LJ, Betz JM, Coates PM.

Anal Bioanal Chem. 2013 May;405(13):4437-41. doi: 10.1007/s00216-013-6864-7.

PMID:
23552970
12.

Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum.

Botelho JC, Shacklady C, Cooper HC, Tai SS, Van Uytfanghe K, Thienpont LM, Vesper HW.

Clin Chem. 2013 Feb;59(2):372-80. doi: 10.1373/clinchem.2012.190934.

13.

Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency.

Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S.

Am J Transplant. 2012 Sep;12(9):2487-97. doi: 10.1111/j.1600-6143.2012.04131.x.

14.

Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer.

Campbell SB, Walker R, Tai SS, Jiang Q, Russ GR.

Am J Transplant. 2012 May;12(5):1146-56. doi: 10.1111/j.1600-6143.2012.04004.x.

15.

Development and certification of a standard reference material for vitamin D metabolites in human serum.

Phinney KW, Bedner M, Tai SS, Vamathevan VV, Sander LC, Sharpless KE, Wise SA, Yen JH, Schleicher RL, Chaudhary-Webb M, Pfeiffer CM, Betz JM, Coates PM, Picciano MF.

Anal Chem. 2012 Jan 17;84(2):956-62. doi: 10.1021/ac202047n.

16.

Preparation and value assignment of standard reference material 968e fat-soluble vitamins, carotenoids, and cholesterol in human serum.

Thomas JB, Duewer DL, Mugenya IO, Phinney KW, Sander LC, Sharpless KE, Sniegoski LT, Tai SS, Welch MJ, Yen JH.

Anal Bioanal Chem. 2012 Jan;402(2):749-62. doi: 10.1007/s00216-011-5447-8.

PMID:
22015475
18.

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.

Flechner SM, Glyda M, Cockfield S, GrinyĆ³ J, Legendre Ch, Russ G, Steinberg S, Wissing KM, Tai SS.

Am J Transplant. 2011 Aug;11(8):1633-44. doi: 10.1111/j.1600-6143.2011.03573.x. Erratum in: Am J Transplant. 2012 Jan;12(1):268.

19.

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians.

Suriapranata IM, Tjong WY, Wang T, Utama A, Raharjo SB, Yuniadi Y, Tai SS.

BMC Med Genet. 2011 Jun 6;12:80. doi: 10.1186/1471-2350-12-80.

20.

Murine tyrosinase inhibitors from Cynanchum bungei and evaluation of in vitro and in vivo depigmenting activity.

Ding HY, Chang TS, Shen HC, Tai SS.

Exp Dermatol. 2011 Sep;20(9):720-4. doi: 10.1111/j.1600-0625.2011.01302.x.

PMID:
21615508
Items per page

Supplemental Content

Support Center